Literature DB >> 1679542

Quantitative and qualitative standards for islet isolation assessment in humans and large mammals.

C Ricordi1.   

Abstract

Several procedures have been recently developed to separate and purify pancreatic islets from large mammals, including humans. It is often difficult to interpret and compare results, mainly because of lack of standardization of criteria for Islet Isolation Assessment (IIA). In small animals, such as rodents, it is generally not a problem to identify and count all the islet tissue retrieved, due to the small numbers with which we are dealing in these species. In larger mammals, several hundred thousand islets can be obtained from a single pancreas, making it critical to correctly sample, identify, count, and verify insulin-producing tissue. The purpose of this workshop was to discuss and determine minimal, simple requirements for IIA, not to indicate absolute parameters for islet count, purity, or function. Both quantitative and qualitative criteria for IIA have been discussed, the main topics being determination of islet number, islet volume, purity of final preparations, documentation of morphologic integrity, viability tests, in vitro function studies (static incubation and perifusion), and in vivo function studies after transplantation in diabetic athymic rodents.

Entities:  

Mesh:

Year:  1991        PMID: 1679542     DOI: 10.1097/00006676-199103000-00018

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  26 in total

1.  Human islet isolation and transplantation in chronic pancreatitis using the automated method.

Authors:  P A Fontes; H L Rilo; P B Carroll; A G Tzakis; R Selby; A J Demetris; T E Starzl; C Ricordi
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

2.  A replacement for islet equivalents with improved reliability and validity.

Authors:  Han-Hung Huang; Karthik Ramachandran; Lisa Stehno-Bittel
Journal:  Acta Diabetol       Date:  2013-10       Impact factor: 4.280

3.  Quantification of basal and stimulated ROS levels as predictors of islet potency and function.

Authors:  B Armann; M S Hanson; E Hatch; A Steffen; L A Fernandez
Journal:  Am J Transplant       Date:  2007-01       Impact factor: 8.086

4.  Detection of intrahepatic human islets following combined liver-islet allotransplantation.

Authors:  C Ricordi; A Tzakis; R Alejandro; Y Zeng; A J Demetris; P Carroll; J J Fung; D H Mintz; T E Starzl
Journal:  Pancreas       Date:  1992       Impact factor: 3.327

5.  Update on islet cell transplantation for type 1 diabetes.

Authors:  Avinash Agarwal; Kenneth L Brayman
Journal:  Semin Intervent Radiol       Date:  2012-06       Impact factor: 1.513

6.  The long noncoding RNA MALAT1 predicts human pancreatic islet isolation quality.

Authors:  Wilson Km Wong; Guozhi Jiang; Anja E Sørensen; Yi Vee Chew; Cody Lee-Maynard; David Liuwantara; Lindy Williams; Philip J O'Connell; Louise T Dalgaard; Ronald C Ma; Wayne J Hawthorne; Mugdha V Joglekar; Anandwardhan A Hardikar
Journal:  JCI Insight       Date:  2019-07-30

7.  Large scale isolation, growth, and function of porcine neonatal islet cells.

Authors:  G S Korbutt; J F Elliott; Z Ao; D K Smith; G L Warnock; R V Rajotte
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

8.  Human islet mass, morphology, and survival after cryopreservation using the Edmonton protocol.

Authors:  Priya M Miranda; Viswanathan Mohan; Sekhar Ganthimathy; Ranjit M Anjana; S Gunasekaran; Venkatachalam Thiagarajan; Thomas A Churchill; Tatsuya Kin; A M James Shapiro; Jonathan R T Lakey
Journal:  Islets       Date:  2013 Sep-Dec       Impact factor: 2.694

Review 9.  Glycemic Outcomes of Islet Autotransplantation.

Authors:  Mohammed E Al-Sofiani; Michael Quartuccio; Erica Hall; Rita Rastogi Kalyani
Journal:  Curr Diab Rep       Date:  2018-09-28       Impact factor: 4.810

10.  Islet preparation purity is overestimated, and less pure fractions have lower post-culture viability before clinical allotransplantation.

Authors:  J P Kitzmann; T Karatzas; K R Mueller; E S Avgoustiniatos; A C Gruessner; A N Balamurugan; M D Bellin; B J Hering; K K Papas
Journal:  Transplant Proc       Date:  2014 Jul-Aug       Impact factor: 1.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.